RLMD - Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying | Benzinga
The Dow Jones index closed lower by more than 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Processa Pharmaceuticals
- The Trade: Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) CEO George Ng acquired a total of 10,000 shares an average price of $2.70. To acquire these shares, it cost around $27,000. The company’s Director Justin W Yorke also bought 8,000 shares of the company.
- What’s Happening: ...